←Back to Expert Scholars
Translational Medicine / 转化医学Indolent Lymphoma Therapy
Sven de Vos
MD, PhD
🏢University of California Los Angeles🌐USA
Professor of Medicine, Hematology Oncology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sven de Vos has contributed to trials of rituximab combinations, BTK inhibitors, and novel targeted therapies in marginal zone and follicular lymphomas at UCLA. He is a longstanding investigator in indolent B cell lymphoma clinical research.
Share:
🧪Research Fields 研究领域
marginal zone lymphoma
follicular lymphoma
novel agents
CD20 antibodies
lymphoma trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sven de Vos 的研究动态
Follow Sven de Vos's research updates
留下邮箱，当我们发布与 Sven de Vos（University of California Los Angeles）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment